Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.

MLA

Zancong Shen, et al. “Pharmacokinetics, Pharmacodynamics, and Safety of Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Adult Males.” Drug Design, Development & Therapy, vol. 9, July 2015, pp. 3423–33. EBSCOhost, https://doi.org/10.2147/DDDT.S85193.

APA

Zancong Shen, Rowlings, C., Kerr, B., Hingorani, V., Manhard, K., Quart, B., Li-Tain Yeh, & Storgard, C. (2015). Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males. Drug Design, Development & Therapy, 9, 3423–3433. https://doi.org/10.2147/DDDT.S85193

Chicago

Zancong Shen, Colin Rowlings, Brad Kerr, Vijay Hingorani, Kimberly Manhard, Barry Quart, Li-Tain Yeh, and Chris Storgard. 2015. “Pharmacokinetics, Pharmacodynamics, and Safety of Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Adult Males.” Drug Design, Development & Therapy 9 (July): 3423–33. doi:10.2147/DDDT.S85193.